Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 11, Number 6—June 2005

Dispatch

Methicillin-resistant Staphylococcus aureus in Community-acquired Skin Infections

Gregory J. Moran*†Comments to Author , Ricky N. Amii*, Fredrick M. Abrahamian*†, and David A. Talan*†
Author affiliations: *Olive View–University of California at Los Angeles (UCLA) Medical Center, Sylmar, California, USA; †David Geffen School of Medicine at UCLA, Los Angeles, California, USA

Main Article

Table

Clinical features and epidemiologic characteristics of patients with skin and soft tissue infections*

Feature/characteristic MRSA, n = 44 (%) Other pathogens, n = 52 (%)
Hospitalized in last year 6 (14) 6 (12)
Prior, unsuccessful antimicrobial drug treatment 15 (34) 15 (29)
Injection drug use 9 (20) 16 (31)
Jail in last year† 3/36 (8) 3/48 (6)
Homeless 9 (20) 10 (19)
Abscess present 41 (93) 44 (85)

*MRSA, methicillin-resistant Staphylococcus aureus.
†This information was not available for 8 MRSA patients and 4 patients with other pathogens.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO